BackPrometheus Biosciences Overview

Prometheus Biosciences Total Assets

Prometheus Biosciences's total assets is $760M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$758.41M
↑ 199.08% YoYΔ $504.83M vs prior year quarter

Peer trimmed avg / median

Loading

Prometheus Biosciences Total Assets History

Loading

Prometheus Biosciences vs. peers: Total Assets Comparison

Loading

Prometheus Biosciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Prometheus Biosciences (RXDX) FAQ

As of the most recent data (March 2023), RXDX shows a total assets of $760M. That compares with $250M in the prior-year period — up 199.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RXDX's total assets is now $760M (was $250M) — a 199.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Prometheus Biosciences is outperforming or lagging.

Tracking RXDX's total assets over time shows whether Prometheus Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $760M That compares with $250M in the prior-year period — up 199.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Prometheus Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $760M) with ownership activity and broader fundamentals.

Prometheus Biosciences's total assets is $760M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.